Enhanced long-term potentiation in the hippocampus of rats expressing mutant presenillin-1 is age related

Neurobiology of Disease

Volumn 12, Issue 3, 2003, Pages 212-224

  Pybus, Ruth ^a   Barnard, Eleanor ^b   Estibeiro, Peter ^b   Mullins, John ^a   MacLeod, Nikki ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ExpressOn BioSystems Ltd   (United Kingdom)

Author keywords

Alzheimer's disease; Electrophysiology; Hippocampus

Indexed keywords

MUTANT PROTEIN; PRESENILIN 1;

AGE; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; DENTATE GYRUS; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; EXTRACELLULAR SPACE; GENE EXPRESSION; GENE MUTATION; GENETIC ENGINEERING; HIPPOCAMPUS; IN VITRO STUDY; INTRACELLULAR RECORDING; LONG TERM POTENTIATION; NONHUMAN; POST TETANIC POTENTIATION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RAT STRAIN; TRANSGENIC ANIMAL; WILD TYPE;

EID: 0038417858     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00016-0     Document Type: Article

References (44)

1. Annaert W., Cupers P., Saftig P., De Strooper B. Presenilin function in APP processing. Ann. NY Acad. Sci. 920:2000;158-164.
2. Annaert W., De Strooper B. Presenilins molecular switches between proteolysis and signal transduction . Trends Neurosci. 22:1999;439-443.
3. Barrow P.A., Empson R.M., Gladwell S.J., Anderson C.M., Killick R., Yu X., Jefferys J.G., Duff K. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 7:2000;119-126.
4. Begley J.G., Duan W., Chan S., Duff K., Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72:1999;1030-1039.
5. Blacker D., Tanzi R.E. The genetics of Alzheimer disease current status and future prospects . Arch. Neurol. 55:1998;294-296.
6. Bortolotto Z.A., Collingridge G.L. Characterization of ltp induced by the activation of glutamate metabotropic receptors in area ca1 of the hippocampus. Neuropharmacology. 32:1993;1-9.
7. Buxbaum J.D., Choi E.K., Luo Y., Lilliehook C., Crowley A.C., Merriam D.E., Wasco W. Calsenilin a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment . Nat. Med. 4:1998;1177-1181.
8. Campbell L.W., Hao S.Y., Thibault O., Blalock E.M., Landfield P.W. Aging changes in voltage-gated calcium currents in hippocampal CA1 neurons. J. Neurosci. 16:1996;6286-6295.
9. Chan S.L., Mayne M., Holden C.P., Geiger J.D., Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 275:2000;18195-18200.
10. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
11. Citron M., Westaway D., Xia W., Carlson G., Diehi T., Levesque G., Johnson Wood, Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St GeorgeHyslopSelkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
12. De Koninck Y., Mody I. The effects of raising intracellular calcium on synaptic GABAA receptor-channels. Neuropharmacology. 35:1996;1365-1374.
13. del Cerro S., Jung M., Lynch G. Benzodiazepines block long-term potentiation in slices of hippocampus and piriform cortex. Neuroscience. 49:1992;1-6.
14. Dewachter I., van Dorpe J., Spittaels K., Tesseur I., Van Den Moechars D., Van Leuven F. Modeling Alzheimer's disease in transgenic mice effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice . Exp. Gerontol. 35:2000;831-841.
15. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-Tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M.N., Holcomb, L., Refolo, Zenk, B., Hardy, J., Younkin, S, 1996. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
16. Guo Q., Christakos S., Robinson N., Mattson M.P. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1 reduced oxidative stress and preserved mitochondrial function . Proc. Natl. Acad. Sci. USA. 95:1998;3227-3232.
17. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport. 8:1996;379-383.
18. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
19. Hirashima N., Etcheberrigaray R., Bergamaschi S., Racchi M., Battaini F., Binetti G., Govoni S., Alkon D.L. Calcium responses in human fibroblasts a diagnostic molecular profile for Alzheimer's disease . Neurobiol. Aging. 17:1996;549-555.
20. Imanishi T., Yamanaka H., Rhee J.S., Akaike N. Interaction between the intracellular Ca2+ stores in rat dissociated hippocampal neurones. Neuroreport. 7:1996;1421-1426.
21. Kovacs D.M., Fausett H.J., Page K.J., Kim T.W., Moir R.D., Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R., Felsenstein K.M., Hyman B.T., Tanzi R.E., Wasco W. Alzheimer-associated presenilins 1 and 2 neuronal expression in brain and localization to intracellular membranes in mammalian cells . Nat. Med. 2:1996;224-229.
22. Kovacs D.M., Mancini R., Henderson J., Na S.J., Schmidt S.D., Kim T.W., Tanzi R.E. Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells. J. Neurochem. 73:1999;2278-2285.
23. Kruman I., Guo Q., Mattson M.P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51:1998;293-308.
24. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
25. Lee M.K., Borchelt D.R., Kim G., Thinakaran G., Slunt H.H., Ratovitski T., Martin L.J., Kittur A., Gandy S., Levey A.I., Jenkins N., Copeland N., Price D.L., Sisodia S.S. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat. Med. 3:1997;756-760.
26. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., LaFeria F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149:2000;793-798.
27. Leissring M.A., LaFeria F.M., Callamaras N., Parker I. Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling. Neurobiol. Dis. 8:2001;469-478.
28. Leissring M.A., Paul B.A., Parker I., Cotman C.W., LaFeria F.M. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J. Neurochem. 72:1999;1061-1068.
29. Leissring M.A., Yamasaki T.R., Wasco W., Buxbaum J.D., Parker I., LaFerla F.M. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc. Natl. Acad. Sci. USA. 97:2000;8590-8593.
30. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D. Calcium signaling in the ER its role in neuronal plasticity and neurodegenerative disorders . Trends Neurosci. 23:2000;222-229.
31. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
32. Nakamura T., Nakamura K., Lasser Ross, Barbara J.G., Sandler V.M., Ross W.N. Inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release evoked by metabotropic agonists and backpropagating action potentials in hippocampal CA1 pyramidal neurons. J. Neurosci. 20:2000;8365-8376.
33. Nathan T., Jensen M.S., Lambert J.D. GABAB receptors play a major role in paired-pulse facilitation in area CA1 of the rat hippocampus. Brain Res. 531:1990;55-65.
34. Parent A., Linden D.J., Sisodia S.S., Borchelt D.R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:1999;56-62.
35. Partridge L.D., Valenzuela C.F. Ca2+ store-dependent potentiation of Ca2+-activated non-selective cation channels in rat hippocampal neurones in vitro. J. Physiol. 521:1999;617-627. Pt 3.
36. Querfurth H.W., Selkoe D.J. Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry. 33:1994;4550-4561.
37. Rall W. Time constants and electrotonic length of membrane cylinders and neurons. Biophys. J. 9:1969;1483-1508.
38. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., Gilis M., Geerts H., Kretzschmar H., Godaux E., Moechars D., Van Leuven F., Herms J. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276:2001;11539-11544.
39. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.L., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
40. Thinakaran G., Harris C.L., Ratovitski T., Davenport F., Slunt H.H., Price D.L., Borchelt D.R., Sisodia S.S. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272:1997;28415-28422.
41. Wigstrom H., Gustafsson B. Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiol. Scand. 125:1985;159-172.
42. Xiao M.Y., Kerpefors M., Gustafsson B., Wigstrom H. On the linkage between AMPA and NMDA receptor-mediated EPSPs in homosynaptic long-term depression in the hippocampal CA1 region of young rats. Neurosci. 15:1995;4496-4506.
43. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack Chung, Handler M., Shen J., Xia W., Tesco G., Saunders A.J., Ding K., Frosch M.P., Tanzi R.E., Kim T.W. Presenilin-mediated modulation of capacitative calcium entry. Neuron. 27:2000;561-572.
44. Zaman S.H., Parent A., Laskey A., Lee M.K., Borchelt D.R., Sisodia S.S., Malinow R. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine. Neurobiol. Dis. 7:2000;54-63.